Abstract
We have examined the incidence of Harvey ras mutations in human squamous cell carcinomas (SCC) of the upper aerodigestive tract using the polymerase chain reaction (PCR) followed by direct sequencing. No mutations were detected at codons 12, 13, 59 or 61 of this gene in any of six papillomas, five erythroplakias, 56 squamous cell carcinomas, and 16 SCC cell lines. Some of the SCC were lymph node metastases (three) or tumours which had recurred following radiotherapy (seven). We conclude that Harvey ras mutations are not a common event in the pathogenesis or recurrence of SCCs from Caucasian subjects, in contrast to the situation with Indian populations (Saranath et al., 1991).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, L., Edington, K., Swan, I. et al. The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Br J Cancer 68, 617–620 (1993). https://doi.org/10.1038/bjc.1993.396
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.396
This article is cited by
-
Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous-Cell Carcinoma: An Enigmatic Entity with Complex Pathogenesis
Journal of Investigative Dermatology (2007)
-
Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form
Oncogene (2003)
-
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15
Oncogene (2003)
-
Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4
Oncogene (2002)
-
TGF-β1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G1 arrest
Oncogene (2002)